Full CoverageTop news
NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19
Fauci says leak concerns fueled his White House revelation of Gilead drug results
By Julie Steenhuysen
Gilead’s remdesivir shows some benefit in early results as coronavirus treatment
By Laurie McGinley & Christopher Rowland
All coverage
FDA OKs Gilead Coronavirus Drug Remdesivir Emergency Use: Trump
By Anna Edney, Michelle Cortez & Justin Sink
FDA issues emergency-use authorization for remdesivir to treat hospitalized patients with severe Covid-19
By Arman Azad & Nicole Chavez
Remdesivir-Maker Gilead's Lobbying Hit New High In 1st Quarter : Shots - Health News
By Sydney Lupkin
Remdesivir Shows Modest Benefits in Coronavirus Trial
By Gina Kolata, Peter Baker & Noah Mercer Weiland
Remdesivir shows success in large COVID-19 trial. Will become 'new standard of care,' Fauci says.
By Nicoletta Lanese
Dr. Anthony Fauci says Gilead's remdesivir will set a new 'standard of care' for coronavirus treatment
By Berkeley Lovelace & Berkeley Lovelace Jr.
Remdesivir: the antiviral drug is being touted as a possible coronavirus treatment – but will it work?
By Melissa Davey
Critical study of Gilead's Covid-19 drug shows patients are responding to treatment, NIH says
By Matthew Herper & Adam Feuerstein